This section presents pharmaceutical projects that are announced from time-to-time around the world.

Lonza Expands its Manufacturing Capabilities at Tampa Site

Lonza announced the completion of the expansion of US million multiphase solid oral dose development and manufacturing capabilities at its Tampa FL USA site

Mapi Pharma to Build a New Sterile Injectable Production Plant in Jerusalem

Mapi Pharma has signed a long term lease agreement at the HarHotzvim HiTech Park in Jerusalem to establish a new sterile production plant for GA Depot injectable products

Colorcon Plans to Build a New Starch Manufacturing Unit

Colorcon announced its plans to build a new starch manufacturing unit in Amsterdam Netherlands This new facility is planned to double the existing manufacturing capacity for Starch Pregelatinised Maize Starch supporting the continued growth of Colorcons excipient business across the world

Kite Announces Plans to Build a New Manufacturing Industry

Kite announces plans to build industryleading cell therapy manufacturing capabilities with a new viral vector facility in Oceanside California

Lonza Announces to Expand HPAPI Development and Manufacturing Capacity

Lonza announced an expansion of Highly Potent API HPAPI capabilities from development to commercial scale manufacturing including formulation and delivery

Tergus Pharma to Build a New Commercial Manufacturing Facility with Great Point Partners

Tergus Pharma partners with Great Point Partners to build a new commercial manufacturing facility A square feet new expansion will provide comprehensive services from development through manufacturing and will become a Contract Development and Manufacturing Organisation or CDMO

Aldevron Breaks Ground to Build 14-Acre Gene Therapy Manufacturing Campus

Aldevron announces its plans to build acre gene therapy manufacturing campus at its headquarters in Fargo

Intertek Expands Pharmaceutical Services

Intertek announced an expansion of the pharmaceutical services for specialist inhalation and nasal product development for biologics in Melbourne near Cambridge

WuXi Biologics Announced Construction of a 69 million Integrated Manufacturing Center in Southwest China

WuXi Biologics commenced construction of a new million integrated manufacturing centre for innovative biologics at Chengdu Southwest China

Thermo Fisher Invests US$ 50 million to Expand Bioproduction Capabilities

Thermo Fisher Scientific announced that it is investing US million in its global bioproduction capabilities

AirBridgeCargo - Air frieght solutions for your Pharma Matcon Efficently handling tablets and powders in IBC's Swiss World Cargo - Pharmaceuticals & Healthcare MECO - 90 Years